Resident scholar at The American Enterprise Institute for Public Policy Research
- Healthcare provisions listed in the Inflation Reduction Act and ramifications for the pharmaceutical and biotechnology industries
- CBO (Congressional Budget Office) scoring process
- Drug pricing and potential legal pushback from big pharmaceutical and biotech companies
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.